313 related articles for article (PubMed ID: 20427397)
21. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
Keller JJ; Offerhaus GJ; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello FM
Clin Cancer Res; 2001 Dec; 7(12):4000-7. PubMed ID: 11751493
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 in sporadic colorectal polyps: immunohistochemical study and its importance in the early stages of colorectal tumorigenesis.
Tatsu K; Hayashi S; Shimada I; Matsui K
Pathol Res Pract; 2005; 201(6):427-33. PubMed ID: 16136748
[TBL] [Abstract][Full Text] [Related]
24. Association between Cyclooxygenase expression and colorectal adenoma characteristics.
Einspahr JG; Krouse RS; Yochim JM; Danenberg PV; Danenberg KD; Bhattacharyya AK; Martínez ME; Alberts DS
Cancer Res; 2003 Jul; 63(14):3891-3. PubMed ID: 12873979
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
26. Colorectal adenoma characteristics as predictors of recurrence.
Bonithon-Kopp C; Piard F; Fenger C; Cabeza E; O'Morain C; Kronborg O; Faivre J;
Dis Colon Rectum; 2004 Mar; 47(3):323-33. PubMed ID: 14991494
[TBL] [Abstract][Full Text] [Related]
27. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
29. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer.
Liang JT; Huang KC; Jeng YM; Lee PH; Lai HS; Hsu HC
Br J Surg; 2004 Mar; 91(3):355-61. PubMed ID: 14991639
[TBL] [Abstract][Full Text] [Related]
30. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy.
Avidan B; Sonnenberg A; Schnell TG; Leya J; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Jun; 97(6):1524-9. PubMed ID: 12094877
[TBL] [Abstract][Full Text] [Related]
31. The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials.
Gao F; Liao C; Liu L; Tan A; Cao Y; Mo Z
Colorectal Dis; 2009 Nov; 11(9):893-901. PubMed ID: 19055515
[TBL] [Abstract][Full Text] [Related]
32. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
[TBL] [Abstract][Full Text] [Related]
33. ß-Catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy.
Brand L; Munding J; Pox CP; Ziebarth W; Reiser M; Hüppe D; Schmiegel W; Reinacher-Schick A; Tannapfel A
Int J Colorectal Dis; 2013 Aug; 28(8):1091-8. PubMed ID: 23516071
[TBL] [Abstract][Full Text] [Related]
34. The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization.
Lanza E; Yu B; Murphy G; Albert PS; Caan B; Marshall JR; Lance P; Paskett ED; Weissfeld J; Slattery M; Burt R; Iber F; Shike M; Kikendall JW; Brewer BK; Schatzkin A;
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1745-52. PubMed ID: 17855692
[TBL] [Abstract][Full Text] [Related]
35. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
Kleibeuker JH; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2203-7. PubMed ID: 14640056
[TBL] [Abstract][Full Text] [Related]
36. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
Benamouzig R; Uzzan B; Little J; Chaussade S
Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of metachronous colorectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence.
Nusko G; Hahn EG; Mansmann U
Scand J Gastroenterol; 2009; 44(6):736-44. PubMed ID: 19277927
[TBL] [Abstract][Full Text] [Related]
38. [Follow-up of a cohort of 2604 colorectal adenomas treated in 1991 and 1992. Search for parameters related to adenomatous recurrence].
Le Bodic L; Cerbelaud C; Bouchand S; Auffret N; Clément A; Le Bodic MF
Gastroenterol Clin Biol; 2003 May; 27(5):466-70. PubMed ID: 12843910
[TBL] [Abstract][Full Text] [Related]
39. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
[TBL] [Abstract][Full Text] [Related]
40. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group.
Schatzkin A; Lanza E; Corle D; Lance P; Iber F; Caan B; Shike M; Weissfeld J; Burt R; Cooper MR; Kikendall JW; Cahill J
N Engl J Med; 2000 Apr; 342(16):1149-55. PubMed ID: 10770979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]